Market News AIOpen the app

Verrica Pharmaceuticals shared its third quarter results, showing record sales of $5.7 million from YCANTH.

ResultsPRORead the original at SEC EDGAR
Good or bad for VRCA?

This is a Prominent story. The full analysis, including whether it is good or bad for VRCA, is available with Pro or after its release time. It opens to free readers on Nov 13, 2026, 4:30 PM ET.

Get alerts for VRCA

Follow Verrica Pharmaceuticals Inc. (VRCA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for VRCA
Free on the App Store and Google Play, or on the web.